Canntab Therapeutics Ltd
Ticker Symbol: USOTC:CTABF
OTC Market Tier: OTCQX International
CIK Number:
Security Type: Ordinary Shares
CTABF Address: 223 Riviera Dr.
Markham, Ontario L3R 5J6
CTABF Country: Canada
CTABF Phone: 289-301-3812
CTABF Fax #: N/A
Website: https://canntab.ca
Description: Canntab Therapeutics is a Canadian cannabis oral dosage formulation company based in Markham, Ont., engaged in the research and development of advanced pharmaceutical-grade formulations of cannabinoids. Canntab has developed patent-pending technology to deliver standardized medical cannabis extract from selective strains in a variety of extended-release/sustained-release pharmaceutical dosages for therapeutic use. In doing so, Canntab has developed a suite of precision oral dose products that are unavailable elsewhere in the marketplace. Canntab's primary focus is on providing cannabis-based products to medical professionals that can be used to deliver therapeutic treatments to their patients. Canntab trades on the Canadian Securities Exchange under the symbol PILL, on the OTCQB Venture Market under the symbol CTABF, and on the Frankfurt Stock Exchange under the symbol TBF1.
SIC Code / Description: N/A / N/A
Shares Authorized:
Shares Outstanding: 25,306,601
Shares Outstanding Date: 04/12/2019
Shares Holder Count: N/A
Shares Holder Date: N/A
Market Capitalization: $ 12,552,074.10
Key Executives: Robert Lefler - Director, Ops.
Robert Lefler - Director, Ops.
Vitor Fonseca - Dir.
Vitor Fonseca - Dir.
Richard Goldstein - CFO
Richard Goldstein - CFO
Geoff Kritzinger - Assistant to the CFO
Geoff Kritzinger - Assistant to the CFO
Vanessa Bain - Exec. Administrator
Vanessa Bain - Exec. Administrator
Jeff Renwick - CEO
Jeff Renwick - CEO
Barry Polisuk - Chairman
Barry Polisuk - Chairman
Number of Employees: 12
Incorporation State: ONT
Incorporation Country: Canada
Incorporation Year: 2016
Auditor: MNP LLP
Auditor Address: Suite 300
111 Richmond St. West
Toronto, ONT M5H 2G4
Canada
Auditor Website: N/A
IR Firm: Mackenzie Research Capital Corporation
IR Firm Address: N/A
IR Firm Website: N/A
Legal Counsel: Garfinkle, Biderman LLP
Legal Counsel Address: 1 Adelaide Street East
1 Adelaide Street East
Toronto, ONT M5C 2V9
CAN
Legal Counsel Website: N/A
Fiscal Year End: 5/31
Reporting Status: International Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Capital Transfer Agency, Inc.
TA Address: 390 Bay Street
Suite 920
Toronto, ONT M5H 2Y2
Canada
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 8,086
Short Date: 08/15/2019
Closing MMID: 8
BFCMmid: 3
Tier ID: 6
Status: Active


Your Recent History
USOTC
CTABF
Canntab Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.